A 50-year-old woman with persistent orthostatic headache is repeatedly misdiagnosed until imaging identifies spontaneous ...

Blood pressure medications are commonly prescribed and are usually well-tolerated, but there are some serious side effects you should know about.

U.S. FILSPARI reaches all-time highs of 908 new PSFs and net product sales of approximately $103 million in 4Q 2025Company ...

Dutasteride is another 5-alpha reductase inhibitor, like finasteride, which works by blocking the male hormone DHT to stop ...

Of particular concern are hip fractures as they carry a high death rate, especially since the elderly often have multiple ...

Johnson & Johnson today announced a new analysis of Phase 3 data which found CAPLYTA® (lumateperone), in combination with an ...

Ex-Vice President Jagdeep Dhankhar hospitalised after fainting spells at 74 Read ahead to know more about his condition and ...

Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for ...

Clinical Study Evaluating a Long-Acting Naltrexone Implant Under the FDA's 505(b)(2) Pathway ANAHEIM, CA - January 14, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer ...

Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.